BEST CEO

PHARMA & HEALTHCARE

Total Income/ 3-yr CAGR

₹ 4,421.98 cr/ 11.87%

PBIT/ 3-yr CAGR

₹ 803.81 cr/41.42%

PAT/ 3-yr CAGR

₹ 652.46 cr/51.32%

3-yr Average TSR

45.85%

Average Market Cap Y-o-Y Growth *

71.16% ROE/ ROCE 19.18%/20.84%

Cash/ Debt

₹ 152.4 cr/ ₹ 455.56 cr

Net Profit Margin

14.94%

*For Oct 2019-Sept 2020; Standalone data; Total income, PBIT & PAT net of extraordinary items; TSR: Total shareholder returns; Source: ACE Equity